These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8113579)

  • 21. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis.
    Batta AK; Salen G; Mirchandani R; Tint GS; Shefer S; Batta M; Abroon J; O'Brien CB; Senior JR
    Am J Gastroenterol; 1993 May; 88(5):691-700. PubMed ID: 8480734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Therapy of primary biliary cirrhosis with ursodeoxycholic acid].
    Lotterer E; Fleig WE
    Z Gastroenterol; 1993 Oct; 31(10):633-5. PubMed ID: 8256481
    [No Abstract]   [Full Text] [Related]  

  • 23. Methotrexate therapy for primary biliary cirrhosis.
    Bach N; Bodian C; Bodenheimer H; Croen E; Berk PD; Thung SN; Lindor KD; Therneau T; Schaffner F
    Am J Gastroenterol; 2003 Jan; 98(1):187-93. PubMed ID: 12526956
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ursodeoxycholic acid in primary biliary cirrhosis. 1: Therapeutic approaches up to now and the rationale for treatment with ursodeoxycholic acid].
    Eisenburg J; Eder M; Spengler U; Berg PA; Caselmann W; Mannes AG; Muntau A
    Fortschr Med; 1988 Nov; 106(34):691-4. PubMed ID: 3061911
    [No Abstract]   [Full Text] [Related]  

  • 25. [Ursodeoxycholic acid in the treatment of primary biliary liver cirrhosis].
    Poupon R
    Gastroenterol Clin Biol; 1994; 18(2 Pt 3):T5-8. PubMed ID: 8045357
    [No Abstract]   [Full Text] [Related]  

  • 26. [Primary biliary cirrhosis. Immunological aggression and aggression by biliary acids].
    Poupon R
    Rev Prat; 1994 May; 44(10):1325-8. PubMed ID: 7939192
    [No Abstract]   [Full Text] [Related]  

  • 27. [Treatment of primary biliary cirrhosis with ursodeoxycholic acid without liver biopsy?].
    Siboni AH
    Ugeskr Laeger; 2004 Aug; 166(32):2688; author reply 2688. PubMed ID: 15347178
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunologic effects of ursodeoxycholic acid in primary biliary cirrhosis.
    Leevy CB; Holt J; Buniak B
    J Assoc Acad Minor Phys; 1993; 4(1):30-2. PubMed ID: 8425102
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of ursodeoxycholic acid in primary biliary cirrhosis.
    Pham NT; Hart LL
    Ann Pharmacother; 1993 Dec; 27(12):1472-4. PubMed ID: 8305782
    [No Abstract]   [Full Text] [Related]  

  • 30. Reflections on therapeutic trials in primary biliary cirrhosis.
    Combes B
    Hepatology; 2005 Nov; 42(5):1009. PubMed ID: 16250047
    [No Abstract]   [Full Text] [Related]  

  • 31. Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.
    Kaplan MM; Poupon R
    Hepatology; 2009 Aug; 50(2):652. PubMed ID: 19309721
    [No Abstract]   [Full Text] [Related]  

  • 32. [Efficacy of combined use of ursodeoxycholic acid and heptral in the treatment of primary biliary cirrhosis].
    Avezov SA; Mansurova FKh
    Klin Med (Mosk); 2004; 82(2):46-9. PubMed ID: 15106512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New weapon for primary biliary cirrhosis from Japan.
    Zeniya M
    J Gastroenterol; 2003; 38(6):619-20. PubMed ID: 12858848
    [No Abstract]   [Full Text] [Related]  

  • 34. Ursodeoxycholic acid reduces increased circulating endothelin 2 in primary biliary cirrhosis.
    Dimoulios P; Kolios G; Notas G; Matrella E; Xidakis C; Koulentaki M; Tsagarakis N; Kouroumalis A; Kouroumalis E
    Aliment Pharmacol Ther; 2005 Feb; 21(3):227-34. PubMed ID: 15691296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term ursodeoxycholic acid delays histological progression in primary biliary cirrhosis.
    Angulo P; Batts KP; Therneau TM; Jorgensen RA; Dickson ER; Lindor KD
    Hepatology; 1999 Mar; 29(3):644-7. PubMed ID: 10051462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Diagnosis and therapy of primary biliary cirrhosis and primary sclerosing cholangitis].
    Stiehl A
    Z Gastroenterol; 2002 Dec; 40 Suppl 2():29-30. PubMed ID: 12467002
    [No Abstract]   [Full Text] [Related]  

  • 37. Medical treatment of primary biliary cirrhosis.
    Kaplan MM
    Semin Liver Dis; 1989 May; 9(2):138-43. PubMed ID: 2658104
    [No Abstract]   [Full Text] [Related]  

  • 38. [Efficacy of combined administration of ursodeoxycholic acid and hepthral in the treatment of primary biliary cirrhosis].
    Avezov SA; Mansurov FKh
    Klin Med (Mosk); 2004; 82(3):55-8. PubMed ID: 15114777
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: complete biochemical and histological response to therapy with ursodesoxycholic acid.
    Renou C; Bourlière M; Martini F; Ouzan D; Penaranda G; Larroque O; Harafa A; Igual JP; Calvet B; Sokolowsky S; Benderitter T; Halfon P
    J Gastroenterol Hepatol; 2006 Apr; 21(4):781-2. PubMed ID: 16677173
    [No Abstract]   [Full Text] [Related]  

  • 40. [Possibilities in the treatment of primary biliary cirrhosis].
    Lengyel G; Tulassay Z
    Orv Hetil; 2005 Jun; 146(23):1245-9. PubMed ID: 15988919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.